Group One Trading, L.P. Tenaya Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
A detailed history of Group One Trading, L.P. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 21,378 shares of TNYA stock, worth $10,261. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,378
Previous 20,665
3.45%
Holding current value
$10,261
Previous $29,000
58.62%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TNYA
# of Institutions
106Shares Held
48.6MCall Options Held
74.4KPut Options Held
78.4K-
Column Group LLC San Francisco, CA9.4MShares$4.51 Million12.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$3.23 Million0.45% of portfolio
-
Woodline Partners LP San Francisco, CA5.92MShares$2.84 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$1.96 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$1.96 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $19.9M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...